Ру O’z Ўзб Eng
+998 71 228-06-96

+998 78 120-16-61

1002
not found
Кенгайтирилган қидирув
    Press-service

    News

    not found

    Victories for disease control

    Amidst many challenges, 2025 delivered significant victories for disease control and elimination. Elimination of mother-to-child disease transmission Maldives became the first country to achieve “triple elimination” of mother-to-child transmission of HIV, syphilis and hepatitis B. Brazil was also recognized for eliminating mother-to-child transmission of HIV, making it the most populous country in the Americas to achieve this historic milestone. Elimination of trachoma, sleeping sickness and river blindness Burundi, Egypt and Fiji eliminated trachoma, while Guinea and Kenya eliminated sleeping sickness. Niger became the first African country to eliminate river blindness. WHO’s Global report on neglected tropical diseases (NTDs) shows 32% fewer people needing treatments against an NTD since 2010, with 867 million people treated in 2023. Decline in deaths from tuberculosis Tuberculosis (TB) deaths declined significantly, with the WHO African and European regions achieving 46% and 49% reductions over the past decade. Yet TB still killed 1.2 million people in 2024, underscoring the need to address risk factors like HIV, diabetes, smoking and undernutrition. Progress in malaria control In 2025, Georgia, Suriname and Timor-Leste were certified malaria-free, and 7 additional new countries in Africa introduced malaria vaccines – a key intervention for child survival. This brings the total to 24 countries, reaching more than 10 million children annually. Wider use of new tools against malaria, including dual-ingredient nets and WHO-recommended vaccines, helped to prevent an estimated 170 million cases and 1 million deaths in 2024. Continued scale-up of vaccination programmes With support from WHO and partners, countries continue scaling up vaccination programmes to protect against diseases including meningitis, pneumococcal disease, polio, rotavirus and HPV (human papillomavirus – a major cause of cervical cancer). On 17 November, the first World Cervical Cancer Elimination Day, WHO and partners announced 86 million girls vaccinated against HPV. In 2025, countries including Bhutan, Brazil, China, Indonesia, Nigeria, Tajikistan, Pakistan and Rwanda expanded HPV vaccination and screening – bringing the world closer to eliminating cervical cancer. Global immunization efforts have led to an 88% drop in measles deaths between 2000 and 2024; nearly 59 million lives have been saved by the measles vaccine since 2000. Despite fewer deaths, measles cases are surging worldwide, with an estimated 11 million infections in 2024 – nearly 800 000 more than pre-pandemic levels in 2019. At least 95% coverage with two measles vaccine doses is required to stop transmission and protect communities from outbreaks of this highly contagious virus. While 89% of infants worldwide received at least one dose against diphtheria, tetanus and polio (DTP), 20 million children missed out on essential vaccines in 2024 due to conflict, supply disruptions, and a rise in vaccine misinformation.

    • 9 January, 12:00
    • Read more
    not found

    Japan to allocate over $2.3 million to modernize Uzbekistan’s blood services

    Japan will provide Uzbekistan with new equipment for 14 blood centers and 3 blood transfusion stations worth over $2.3 million under its Economic and Social Development Program. This is expected to increase the share of voluntarily donated blood products and improve medical services. Uzbekistan’s health minister Asilbek Khudayarov and Japan’s ambassador to Uzbekistan Shinichiro Nakamura signed exchange notes under Japan’s Economic and Social Development Program on 17 December worth 360 million yen (over $2.3 million), the embassy of Japan told Gazeta. Under the grant program, 14 regional blood centers across Uzbekistan, as well as three blood transfusion stations at national clinics will be equipped with modern facilities for the storage and transportation of blood. “The implementation of the project will help meet the country’s growing demand for donor blood and increase the share of blood products derived from voluntary blood donation,” the embassy noted. The diplomatic mission said at the recent first Central Asia-Japan summit in Tokyo, healthcare and the medical sector were identified as one of the priority areas of cooperation between the countries. “The government of Japan intends to continue contributing to improved access to high-quality medical services in Uzbekistan,” the embassy noted.

    • 26 December, 09:25
    • Read more
    not found

    Top 5 Largest Pharma and Healthcare Companies in 2025 By Number of Employees

    As the global pharmaceutical industry continues to evolve, workforce size remains a powerful indicator of operational scale, global reach and breadth of services. In 2025, the largest pharma and healthcare employers span continents and sectors — from traditional drug manufacturing and biotech innovation to retail pharmacy and clinical services. 1. CVS Health (>300,000 employees)CVS Health is the top employer in the pharma‑adjacent space, with more than 300,000 employees as of 2025. Beyond its well-known pharmacy chain, the company operates MinuteClinic health clinics, the Caremark PBM and the Aetna insurance division. In 2024, CVS generated , up 4.2% compared to the previous year. Its fourth quarter revenues also increased 4.2% from the year prior to $97.7 billion. CVS alone owns Aetna, making it one of the most vertically integrated healthcare companies in the US. 2. Walgreens Boots Alliance (~311,000 employees)Walgreens Boots Alliance (WBA) employs approximately 311,000 people, serving markets across the US, UK and beyond. The company is restructuring following a $10 billion acquisition by Sycamore Partners announced in early 2025, which includes the potential divestiture of the Boots division, impacting tens of thousands of employees. The total value of the acquisition is $23.7 billion, including payouts and debts. WBA is transitioning to support digital pharmacy infrastructure and clinical services. 3. Johnson & Johnson (~138,000 employees)J&J’s headcount stands at around 138,000 as of 2025, following a reduction from over 152,000 in 2023 due to restructuring tied to its consumer healthcare spinoff Kenvue. The company continues to invest in pharmaceuticals, particularly in oncology and immunology, and medical devices. In 2024, the company reported $88.8 billion in revenue, representing a 4.3% increase, with Q4 sales up 5.3% from the same quarter in the previous year to $22.5 billion. 4. Sinopharm (~115,959 employees)Sinopharm, China’s state-owned pharmaceutical giant, employs roughly 120,000 people. Covering drug production, vaccine R&D, Traditional Chinese Medicine (TCM) and distribution, Sinopharm was instrumental in China’s COVID-19 response. The company continues expanding globally, especially in emerging markets. Sinopharm Holding ranked 24th on the 2022 Fortune China 500 list and held the top spot among pharmaceutical companies in China. That same year, the company’s Morgan Stanley Capital International (MSCI) Environmental, Social and Governance (ESG) rating was upgraded to “A,” and it was recognized as one of the top 50 centrally state-controlled listed companies for ESG governance. Additionally, Sinopharm ranked 28th among the top 100 most valuable Chinese brands among publicly listed pharmaceutical firms in China. 5. AstraZeneca (~94,300 employees)AstraZeneca grew its workforce to around 94,300 as of the end of 2024, reflecting its expansion in oncology, rare diseases and respiratory therapeutics. Strategic acquisitions — such as Alexion, Amolyt and Fusion — have expanded its research pipeline and extended its footprint in biologics. It also announced an ambitious goal of reaching $80 billion in total revenue by 2030. The company is expecting to launch 20 new drugs by 2030 to help meet this goal. It also announced major investments, including a $570 million expansion of its Canadian footprint.

    • 19 December, 13:00
    • Read more
    not found

    11:45 / 17.12.2025

    Top 20 Largest pharmacy in the world

    not found

    14:42 / 22.10.2025

    Exciting results from blood test for 50 cancers

    not found

    11:55 / 15.10.2025

    New Type of Diabetes Discovered

    not found

    10:17 / 18.08.2025

    A discussion was held on the five-year strategy of the joint-stock company "Dori-Darmon"

    not found

    18:00 / 11.07.2025

    The United States has reported a record number of measles cases since the start of the year — the highest in 25 years

    not found

    09:00 / 25.02.2025

    Adding milk improves the effectiveness of oral drugs

    Нажмите на кнопку ниже, чтобы прослушать текст Powered by GSpeech